TITLE

BLOODBATH OVER ESAs?

AUTHOR(S)
Pfeiffer, Naomi
PUB. DATE
July 2007
SOURCE
Drug Topics;7/23/2007, Vol. 151 Issue 14, p36
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that the U.S. Food & Drug Administration has decided to place boxed warnings n the drug labels of erythropoiesis-stimulating agents (ESA), urging doctors to use the smallest dosage possible to avoid the use of blood transfusions. The warnings followed the results of some studies showing that higher risks accompanied higher doses of ESAs. Amgen Inc. research and development executive vice president Roger M. Perlmutter disagrees that ESAs are widely overprescribed. Members of the Oncologic Drugs Advisory Committee voted to further tighten the use of anti-anemia drugs in general pending the results of further safety studies.
ACCESSION #
26131627

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics